| Kimberly Ann Hill, MD | |
|
310 Sunnyview Ln, Kalispell, MT 59901-3129 | |
| (406) 752-5111 | |
| Not Available |
| Full Name | Kimberly Ann Hill |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 310 Sunnyview Ln, Kalispell, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205221181 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 74495 (Montana) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kalispell Regional Medical Center | Kalispell, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kalispell Regional Medical Center Inc | 5294644381 | 354 |
News Archive
Hospitals across the country are investigating ways to improve their patients' experience through decreasing waiting times in emergency rooms and in immediate care settings.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
In a longitudinal study recently published on the preprint server medRxiv*, Andrea Pilotto et al. find that one-third of COVID-19 infection survivors have long-term neurological manifestations after hospitalization.
The gap in stillbirth rates between indigenous and non-indigenous women in Queensland, Australia, is closing, however indigenous women are still at risk of stillbirth due to preventable causes, find researchers in a new study published today (3 September) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
SynCardia Systems, Inc. announced today that Brigham and Women's Hospital in Boston, and University of Iowa (UI) Hospitals and Clinics in Iowa City, Iowa, have begun certification to implant the SynCardia temporary Total Artificial Heart. Brigham and Women's will complete Phase I of certification on Nov. 1 & 2, and UI Hospitals and Clinics completed Phase I on Oct. 21 & 22.
› Verified 4 days ago
| Entity Name | Kalispell Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
Hospitals across the country are investigating ways to improve their patients' experience through decreasing waiting times in emergency rooms and in immediate care settings.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
In a longitudinal study recently published on the preprint server medRxiv*, Andrea Pilotto et al. find that one-third of COVID-19 infection survivors have long-term neurological manifestations after hospitalization.
The gap in stillbirth rates between indigenous and non-indigenous women in Queensland, Australia, is closing, however indigenous women are still at risk of stillbirth due to preventable causes, find researchers in a new study published today (3 September) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
SynCardia Systems, Inc. announced today that Brigham and Women's Hospital in Boston, and University of Iowa (UI) Hospitals and Clinics in Iowa City, Iowa, have begun certification to implant the SynCardia temporary Total Artificial Heart. Brigham and Women's will complete Phase I of certification on Nov. 1 & 2, and UI Hospitals and Clinics completed Phase I on Oct. 21 & 22.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Ann Hill, MD 310 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 752-5111 | Kimberly Ann Hill, MD 310 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 752-5111 |
News Archive
Hospitals across the country are investigating ways to improve their patients' experience through decreasing waiting times in emergency rooms and in immediate care settings.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has been awarded a $77.2 million contract modification by the U.S. Department of Health & Human Services (HHS) to complete Phase 3 development of its influenza neuraminidase inhibitor, intravenous (i.v.) peramivir, for the treatment of complicated influenza.
In a longitudinal study recently published on the preprint server medRxiv*, Andrea Pilotto et al. find that one-third of COVID-19 infection survivors have long-term neurological manifestations after hospitalization.
The gap in stillbirth rates between indigenous and non-indigenous women in Queensland, Australia, is closing, however indigenous women are still at risk of stillbirth due to preventable causes, find researchers in a new study published today (3 September) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
SynCardia Systems, Inc. announced today that Brigham and Women's Hospital in Boston, and University of Iowa (UI) Hospitals and Clinics in Iowa City, Iowa, have begun certification to implant the SynCardia temporary Total Artificial Heart. Brigham and Women's will complete Phase I of certification on Nov. 1 & 2, and UI Hospitals and Clinics completed Phase I on Oct. 21 & 22.
› Verified 4 days ago
Dr. Dallas Tanner Koperski, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-7133 | |
Theodore Losey, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-751-7122 | |
Scott D Burry, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-1733 | |
Robert W Bates, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-1733 | |
Dr. Tyler Cameron Hoppes, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-1733 | |
William Keith Lara, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 Sunnyview Ln, Emergency Dept, Kalispell, MT 59901 Phone: 406-752-1708 Fax: 406-755-0971 |